Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Osteomyelitis due to Staphylococcus aureus (Disease Or Phenotype)

Medcin:MEDCIN:352937

Id:dc173a19-0fc2-5e08-810e-b17395ad9cab

Results found

Linked to

	Label	Description
	Ceftizoxime indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tobramycin indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cephapirin indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Clavulanic Acid indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Clindamycin phosphate indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	4-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cefonicid indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fusidic Acid indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ceftazidime indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ticarcillin indication Osteomyelitis due to Staphylococcus aureus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ceftizoxime indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Tobramycin indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cephapirin indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Clavulanic Acid indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Clindamycin phosphate indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

4-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cefonicid indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fusidic Acid indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ceftazidime indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ticarcillin indication Osteomyelitis due to Staphylococcus aureus

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.